New approaches to sepsis: molecular diagnostics and biomarkers.
about
A Pathophysiological Insight into Sepsis and Its Correlation with Postmortem DiagnosisOxidative-Nitrosative Stress and Myocardial Dysfunctions in Sepsis: Evidence from the Literature and Postmortem ObservationsBiomarkers for Sepsis: What Is and What Might Be?Septic Shock: Advances in Diagnosis and TreatmentBioanalytical chemistry of cytokines--a reviewHepatosplanchnic circulation in cirrhosis and sepsisUse of rapid diagnostic techniques in ICU patients with infectionsMultiplex PCR system for rapid detection of pathogens in patients with presumed sepsis - a systemic review and meta-analysisAdministration of a CXCL12 Analog in Endotoxemia Is Associated with Anti-Inflammatory, Anti-Oxidative and Cytoprotective Effects In VivoClinical Significance of Molecular Diagnostic Tools for Bacterial Bloodstream Infections: A Systematic ReviewThe role of genetics and antibodies in sepsisUrosepsis--Etiology, Diagnosis, and TreatmentResveratrol alleviates endotoxin-induced myocardial toxicity via the Nrf2 transcription factorThe IRIDICA BAC BSI Assay: Rapid, Sensitive and Culture-Independent Identification of Bacteria and Candida in BloodA Molecular Host Response Assay to Discriminate Between Sepsis and Infection-Negative Systemic Inflammation in Critically Ill Patients: Discovery and Validation in Independent CohortsCardiorenal Syndrome in Western Countries: Epidemiology, Diagnosis and Management Approaches.New Consensus Definitions for Sepsis and Septic Shock: Implications for Treatment Strategies and Drug Development?Sepsis affects most routine and cell population data (CPD) obtained using the Sysmex XN-2000 blood cell analyzer: neutrophil-related CPD NE-SFL and NE-WY provide useful information for detecting sepsis.Clinical significance of cell population data (CPD) on Sysmex XN-9000 in septic patients with our without liver impairment.Validation of two multiplex platforms to quantify circulating markers of inflammation and endothelial injury in severe infection.Discovery and validation of biomarkers to guide clinical management of pneumonia in African childrenDecreased HLA-DR antigen-associated invariant chain (CD74) mRNA expression predicts mortality after septic shock.Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.Diagnostic utility of broad range bacterial 16S rRNA gene PCR with degradation of human and free bacterial DNA in bloodstream infection is more sensitive than an in-house developed PCR without degradation of human and free bacterial DNA.Identification of four novel serum protein biomarkers in sepsis patients encoded by target genes of sepsis-related miRNAs.Sepsis induced by Staphylococcus aureus: participation of biomarkers in a murine model.Microbiological characteristics of sepsis in a University hospitalDevelopments for improved diagnosis of bacterial bloodstream infections.Diagnostic accuracy of presepsin (sCD14-ST) for prediction of bacterial infection in cerebrospinal fluid samples from children with suspected bacterial meningitis or ventriculitis.Human metabolic response to systemic inflammation: assessment of the concordance between experimental endotoxemia and clinical cases of sepsis/SIRS.Relationship of serum mannose-binding lectin levels with the development of sepsis: a meta-analysis.Procalcitonin is a marker of gram-negative bacteremia in patients with sepsis.Interleukin-10 rs2227307 and CXCR2 rs1126579 polymorphisms modulate the predisposition to septic shock.The Synthetic Antimicrobial Peptide 19-2.5 Interacts with Heparanase and Heparan Sulfate in Murine and Human SepsisEarly and dynamic changes in gene expression in septic shock patients: a genome-wide approachOrigin of Circulating Free DNA in Sepsis: Analysis of the CLP Mouse Model.The Clinical Challenge of Sepsis Identification and MonitoringLipoproteins/peptides are sepsis-inducing toxins from bacteria that can be neutralized by synthetic anti-endotoxin peptides.Heparin-Binding Protein Measurement Improves the Prediction of Severe Infection With Organ Dysfunction in the Emergency DepartmentExtended leukocyte differential count and C-reactive protein in septic patients with liver impairment: diagnostic approach to evaluate sepsis in intensive care unit.
P2860
Q26745458-0C952D4E-0A10-4075-8264-8025FD7DE993Q26747626-ABA15787-1B4A-4B14-B408-17CAB6230953Q26785255-EA22C969-3FE5-4192-8FE5-489E4F1963A5Q26797235-DFBDD05F-9BD8-4AB8-B01F-B9AEC837C9CEQ26851317-23B5F190-11ED-4911-9ED6-FB6D78627ED2Q26864350-86FA7ED2-DDDD-4710-B5B6-CA6C40099667Q26866463-46784279-4C82-4F1C-AA45-B2DAFEC8A8A2Q27002913-ECE88ACC-E03F-4B43-816E-85A7C9229EF2Q27317106-A8DB597E-B943-414A-9A17-8710D2935A93Q28066979-84A50AA5-90CC-4C39-8E65-0B60E76FA3B5Q28075279-C8755FF7-26D8-4CE8-85BC-CA1BBAB8C0F9Q28078523-27A66C53-F3B8-4602-A811-521308802A16Q28534757-7827B9EE-C800-48F9-9130-7F17588F29E9Q28552374-DD8B22D9-3498-407D-884F-6FDCF826FD8CQ28606587-318A786B-1F40-4298-870E-D665693A5E9CQ30235589-2EF90E3C-2D29-4FAE-9875-F0062A530532Q30235974-305EC216-BE3D-41FB-94E8-2DD8B517A60DQ30827175-DF0B9AC3-28C9-4DC9-A4AA-1BE27534C46EQ31148178-466AE1AA-49FA-410B-995B-CA09A8E79828Q33574264-AC80A137-1AE6-4D62-854A-8EE4904130CFQ33678141-098A7E44-F5F3-4E2D-8CA2-851FAA3BE31AQ33749935-C6F632B3-439D-4BC0-83D7-3323A966644DQ33828888-BC4F49BC-C0A5-40FE-893A-A38083CC2866Q33998490-EE3EE0C6-AA87-4C1D-B498-2DA30E0E6419Q34368811-B385DCB7-A4AE-471E-A03B-F2E75B4B74FDQ35063462-D6CE3B8E-03E0-4A5E-A2E1-20A26237E641Q35101906-D3CA3904-6A4A-4F89-894A-60ECFDCAC6ACQ35171979-57E603CC-B6F9-44CF-B401-D34312DDB396Q35193178-CBE30EDF-6AF9-4CEB-9D8D-8136821CC28FQ35247557-14F554E6-66A8-48BC-A88F-595560823D02Q35342497-D73267AA-501A-46A4-8A81-178A46B3CAD1Q35670631-693F0160-10AF-4E7B-BF17-8F1D96C7102CQ35849269-A2F9D5E8-D127-46CA-9889-74FDC23C9E7DQ35850606-9F617579-4491-43E5-A355-20EA283C115DQ35883538-D43EE037-30B4-46C3-B849-DD7C8C5F434FQ35931077-20E52586-38C7-4845-A47D-9A6EC3B57B89Q36020055-BFB40AC4-A546-4620-8F7D-B863C563E068Q36099284-1E43DE2B-57EC-4D61-8F05-328542E99FB0Q36154747-A53633B4-C78C-41B9-890D-C0A5CA5147D8Q36204941-3583230F-BB92-4F48-AB62-9E1C2F264FE9
P2860
New approaches to sepsis: molecular diagnostics and biomarkers.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
New approaches to sepsis: molecular diagnostics and biomarkers.
@ast
New approaches to sepsis: molecular diagnostics and biomarkers.
@en
New approaches to sepsis: molecular diagnostics and biomarkers.
@nl
type
label
New approaches to sepsis: molecular diagnostics and biomarkers.
@ast
New approaches to sepsis: molecular diagnostics and biomarkers.
@en
New approaches to sepsis: molecular diagnostics and biomarkers.
@nl
prefLabel
New approaches to sepsis: molecular diagnostics and biomarkers.
@ast
New approaches to sepsis: molecular diagnostics and biomarkers.
@en
New approaches to sepsis: molecular diagnostics and biomarkers.
@nl
P2093
P2860
P356
P1476
New approaches to sepsis: molecular diagnostics and biomarkers
@en
P2093
Christiane S Hartog
Konrad Reinhart
Niels C Riedemann
P2860
P304
P356
10.1128/CMR.00016-12
P407
P577
2012-10-01T00:00:00Z